美國顯影劑和放射性藥物市場：Medtech 360

Contrast Agents and Radiopharmaceuticals | Medtech 360 | Market Insights | United States

出版日期: 2024年06月25日 | 出版商:

Clarivate | 英文 | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計美國顯影劑和放射性藥物市場在整個預測期內將出現溫和成長。 PET 和 MRI 檢查數量的增加以及 CEUS 和 PET 檢查中顯影劑使用的擴大推動了市場成長。然而，由於人們仍然擔心某些方式中的钆和輻射暴露，因此市場受到一定程度的限制。此外，向「基於價值的醫學」的轉變可能會對某些手術造成障礙，反而有利於提供最高水準的精確度和清晰可視化的手術。未來的市場發展將由目前正在開發或臨床試驗中的新型顯影劑的推出，以及FDA對現有顯影劑核准推動。

本報告提供了 2019-2033 年美國顯影劑和放射性藥物市場的全面資料和分析。

FDA核准PSMA PET 顯影劑的數量正在逐漸增加。

哪些 PET 顯影劑獲得 FDA核准？
這些 PSMA PET 顯影劑有哪些優點？
它被核准用於哪些適應症？

製造商正在積極參與顯影劑產品的臨床評估。

哪些類型的顯影劑正在接受臨床評估？
與現有顯影劑相比有哪些優勢？

FDA 擴大了在放射治療中使用 CEUS 的核准。

該核准適用什麼程序？未來可能會核准哪些額外的治療方法？
哪些顯影劑獲得 FDA核准？
FDA 的這些核准將如何改變競爭格局？

對钆滯留效應的擔憂似乎會對造影增強 MRI 的使用產生負面影響。

ACO、健康網路和醫生對钆保留的最新見解有何反應？
鎖狀GBCA 和大環 GBCA 之間的主要差異是什麼？未來這些產品的市場需求將如何改變？
其他顯像模式會主導造影增強 MRI 程式的市場嗎？
哪些公司（及相關產品）將受益於向大環 GBCA 的轉變？

The US contrast agents and radiopharmaceutical market will see moderate growth over the forecast period. Market growth will be driven by rising PET and MRI procedure volumes, and the expanding use of imaging agents in CEUS and PET procedures. However, the market will be somewhat limited by the continued concern over gadolinium and radiation exposure in certain modalities. Additionally, the shift toward value-based care will act as a barrier for certain procedures, favoring those that offer the highest levels of accuracy and clarity in visualization instead. Moving forward, market growth will be driven by the introduction of new contrast agents currently in development or undergoing clinical trials, along with FDA approvals for expanded indications of existing contrast agents.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for contrast agents and radiopharmaceuticals in the US from 2019 through 2033.

There has been a gradual increase in the number FDA approvals for PSMA PET imaging agents.

Which PET imaging agents have received FDA approval?
What advantages do these PSMA PET imaging agents offer?
What indications are they approved for?

Manufacturers are actively engaging in ongoing clinical evaluation of their contrast agent products.

Which contrast agent products are under clinical evaluation?
What advantage do they offer over the existing contrast agents in the market.

The FDA expanded approval for the use of CEUS in radiology procedures.

What type of procedures does this approval extend to? What additional procedures could be approved in the future?
Which contrast agents have received FDA approval?
How will these FDA approvals change the competitive landscape.

Looming concerns over the effects of gadolinium retention will negatively affect the use of contrast-enhanced MRI.

How are ACOs, health networks, and physicians responding to the recent findings on gadolinium retention?
What are the key differences between linear and macrocyclic GBCAs, and how will market demand for these products shift going forward?
Will other imaging modalities cannibalize contrast-enhanced MRI procedures?
Which companies (and associated products) will benefit from the shift to macrocyclic GBCAs?

United States

Abstract

Executive Summary

COVID-19 Updates
Market Highlights
Competitive Highlights
Market Developments
Procedures and Products Covered

Key Report Updates

Contrast Agent and Radiopharmaceutical Market

Market Highlights
- Key Content Updates
Market Definitions
Market Forecast Data
Market Shares
Competitive Insights
- Cardinal Health
- GE Healthcare
- Bracco Group
- Lantheus Holdings
- Bayer Healthcare
- Other Key Competitors
- Factors Affecting All Competitors
Market Developments

Radiopharmaceutical Market

Market Highlights
- Key Content Updates
Market Definitions
Market Forecast Data
Market Shares
Competitive Insights
- US Radiopharmaceutical Market Competitive Insights

CT and X-Ray Contrast Agent Market

Market Highlights
- Key Content Updates
Market Definitions
Market Forecast Data
Market Shares
Competitive Insights
- US CT and X-Ray Contrast Agent Market Competitive Insights

MRI Contrast Agent Market

Market Highlights
- Key Content Updates
Market Definitions
Market Forecast Data
Market Shares
Competitive Insights
- US MRI Contrast Agent Market Competitive Insights
- Factors Affecting All Competitors

Ultrasound Contrast Agent Market

Market Highlights
- Key Content Updates
Market Definitions
Market Forecast Data
Market Shares
Competitive Insights
- US Ultrasound Contrast Agent Market Competitive Insights

Appendix

Abbreviations
Bibliography

Tables and Figures

Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2019-2033
Contrast Agent and Radiopharmaceutical Market Landscape, US (USD), 2023 and 2033
Competitive Insights
Contrast Agent and Radiopharmaceutical Market Share Rankings, by Product Type, US, 2023
Companies Mentioned
Recent Events in the Contrast Agent and Radiopharmaceutical Market, US
Key Clinical Trials in the Contrast Agent and Radiopharmaceutical Market, US
Emerging Products for the Contrast Agent and Radiopharmaceutical Market, US
Contrast Agent and Radiopharmaceutical Procedures and Products Covered, US
US Contrast Agent and Radiopharmaceutical Market Drivers
US Contrast Agent and Radiopharmaceutical Market Limiters
Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2019-2033
Contrast Agent and Radiopharmaceutical Procedures, by Product Type, US, 2019-2033
Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2019-2033
Contrast Agent and Radiopharmaceutical Revenue Market Shares, US, 2023
Contrast Agent and Radiopharmaceutical Revenue Market Shares, by Product Type, US, 2023
Cardinal Health Competitive Insights
GE Healthcare Competitive Insights
Bracco Group Competitive Insights
Lantheus Holdings Competitive Insights
Bayer Healthcare Competitive Insights
Competitive Insights for Other Key Competitors
Recent Events in the Contrast Agent and Radiopharmaceutical Market, US
Key Clinical Trials in the Contrast Agent and Radiopharmaceutical Market, US
Emerging Products for the Contrast Agent and Radiopharmaceutical Market, US
US Radiopharmaceutical Market Drivers
US Radiopharmaceutical Market Limiters
Radiopharmaceutical Market, by Product Type, US (USD), 2019-2033
Radiopharmaceutical Market, by Product Type, US (USD), 2019-2033
Radiopharmaceutical Market Growth, by Product Type, US, 2020-2033
Nuclear Medicine System Installed Base, by Product Type, US, 2019-2033
Radiopharmaceutical Revenue Market Shares, US, 2023
Radiopharmaceutical Revenue Market Shares, by Product Type, US, 2023
US CT and X-Ray Contrast Agent Market Drivers
US CT and X-Ray Contrast Agent Market Limiters
CT and X-Ray Contrast Agent Market, by Product Type, US (USD), 2019-2033
CT and X-Ray Contrast Agent Market, by Product Type, US (USD), 2019-2033
CT and X-Ray Contrast Agent Market Growth, by Product Type, US, 2020-2033
CT and X-Ray System Installed Base, by Product Type, US, 2019-2033
CT Contrast Agent Market, by Procedure Type, US (USD), 2019-2033
CT Contrast Agent Market Growth, by Procedure Type, US, 2020-2033
X-Ray, Contrast Agent Market, by Procedure Type, US (USD), 2019-2033
CT and X-Ray Contrast Agent Revenue Market Shares, US, 2023
CT and X-Ray Contrast Agent Revenue Market Shares, US, 2023
US MRI Contrast Agent Market Drivers
US MRI Contrast Agent Market Limiters
MRI Contrast Agent Market, by Procedure Type, US (USD), 2019-2033
MRI Contrast Agent Market, by Procedure Type, US (USD), 2019-2033
MRI Contrast Agent Market Growth, by Procedure Type, US, 2020-2033
MRI System Installed Base, US, 2019-2033
MRI Contrast Agent Revenue Market Shares, US, 2023
MRI Contrast Agent Revenue Market Shares, US, 2023
US Ultrasound Contrast Agent Market Drivers
US Ultrasound Contrast Agent Market Limiters
Ultrasound Contrast Agent Market, US (USD), 2019-2033
Ultrasound Contrast Agent Market, US (USD), 2019-2033
Ultrasound Contrast Agent Revenue Market Shares, US, 2023
Ultrasound Contrast Agent Revenue Market Shares, US, 2023